Romanian National Registry of Outcomes After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis - RO-TAVI

  • End date
    Jul 30, 2023
  • participants needed
  • sponsor
    Romanian Society of Cardiology
Updated on 26 January 2021


RO-TAVI is a national prospective, observational, multi-center registry registry of patients with aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI) to assess patient care and outcomes.


Background: Since the establishment of transcatheter aortic valve implantation (TAVI) in Romania in 2015 there has been a growing number of interventions being performed by an increasing number of hospitals throughout the country. In 2018, there were more than 250 implants, which are expected to grow in the following years by about 30% on an annual basis.

Objective: This is a national quality assurance initiative to improve patient care and outcomes. It further serves as a database for the assessment of the safety and efficacy of TAVI and its financial implications (e.g. reimbursement).

Design: National, prospective, observational, multi-center registry. All centers performing TAVI in Romania; minimum cases per center for inclusion: 20 cases/year-to-date Population: All patients undergoing TAVI in Romania at any of the participating centers with a CE-marked valve of any manufacturer given that they provide written informed consent.

Condition Aortic Stenosis, VALVULAR HEART DISEASE, Heart Valve Disease, Symptomatic Aortic Stenosis, Aortic Stenosis Symptomatic, Heart Valve Disease, aortic valve stenosis
Treatment Transcatheter Aortic Valve Implantation
Clinical Study IdentifierNCT04694859
SponsorRomanian Society of Cardiology
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

severe symptomatic aortic valve stenosis
high risk or patients deemed amenable for TAVI by a multidisciplinary team
signed informed consent to participate in the study

Exclusion Criteria

inadequate annulus size (<18 mm, >29 mm)
left ventricle thrombus
active endocarditis
high risk of coronary ostium obstruction
plaques with mobile thrombi in the ascending aorta, or arch
hemodynamic instability
estimated life expectancy <1 year
comorbidity suggesting lack of improvement of quality of life
other situations adjudicated by the local HeartTeam
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note